Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients. (2015)
Attributed to:
MICA: MRC Centre for Neuromuscular Diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/cei.12616
PubMed Identifier: 25731216
Publication URI: http://europepmc.org/abstract/MED/25731216
Type: Journal Article/Review
Volume: 181
Parent Publication: Clinical and experimental immunology
Issue: 1
ISSN: 0009-9104